FDA recall D-1437-2014

Teva Pharmaceuticals USA · Class III · drug

Product

Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only Teva Pharmaceuticals, USA, Sellersville, PA. NDC 51285-114-58

Reason for recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2014-06-17
Report date
2014-07-23
Termination date
2015-03-09
Voluntary/Mandated
Voluntary: Firm initiated
Location
North Wales, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1437-2014